| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/27/2006 | WO2006044840A2 Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammation |
| 04/27/2006 | WO2006044674A2 G-protein estrogen membrane receptor |
| 04/27/2006 | WO2006043730A1 Method for producing l-amino acids using bacteria of the enterobacteriaceae family |
| 04/27/2006 | WO2006043710A1 Drug development target protein and target gene, and method of screening |
| 04/27/2006 | WO2006043692A1 Pkp3 oncogene as a prognostic indicator for lung cancer |
| 04/27/2006 | WO2006043644A1 Temperature-responsive depsipeptide polymer |
| 04/27/2006 | WO2006043271A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 04/27/2006 | WO2006043079A2 Compositions and methods for the control of mammary cell number |
| 04/27/2006 | WO2006043062A1 Method for the isolation of haptoglobin |
| 04/27/2006 | WO2006043060A2 Mam domain containing protein |
| 04/27/2006 | WO2006042745A2 Chemically modified peptide analogs |
| 04/27/2006 | WO2006042661A2 Oligopeptides and their use in cosmetics |
| 04/27/2006 | WO2006042558A2 Group 2 mite polypeptide variants |
| 04/27/2006 | WO2006042541A1 A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method |
| 04/27/2006 | WO2006042507A1 Immunoadsorber for treating inflammations |
| 04/27/2006 | WO2006042404A1 Method for controlling insects of the order diptera using a bacillus thuringiensis strain |
| 04/27/2006 | WO2006042403A1 Process for producing natural immunobiotic extract and uses thereof |
| 04/27/2006 | WO2006042374A1 Method for separating keratinous proteins from materials |
| 04/27/2006 | WO2006021345A3 Diagnostics and therapeutics for diseases associated with adrenergic alpha-1b receptor (adra1b) |
| 04/27/2006 | WO2006018551A8 Novel peptide and pharmaceutical composition containing said peptide |
| 04/27/2006 | WO2006010891A9 Linkers |
| 04/27/2006 | WO2005124361A3 Uses of gpr100 receptor in diabetes and obesity regulation |
| 04/27/2006 | WO2005123762A3 Codon-optimized hpv16 li for salmonella vaccine strains against human papillomavirus type 16 |
| 04/27/2006 | WO2005123104A3 Use of vegf inhibitors for the treatment of human cancer |
| 04/27/2006 | WO2005122675A3 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proetins |
| 04/27/2006 | WO2005120570A3 Therapeutic targeting of parc/ccl18 and its signaling in pulmonary fibrosis |
| 04/27/2006 | WO2005118627A3 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/27/2006 | WO2005118611A3 Microutrophin and uses thereof |
| 04/27/2006 | WO2005116070A9 Reporter system for detecting signal pathway activation in multiple cell types |
| 04/27/2006 | WO2005113586A3 Disease-associated proteins |
| 04/27/2006 | WO2005111622A3 Diagnostic assay for trypanosoma cruzi infection |
| 04/27/2006 | WO2005108427A3 Method for producing soluble mhc proteins |
| 04/27/2006 | WO2005105842A3 Crystal structure of cytochrome p450 3a4 and uses thereof |
| 04/27/2006 | WO2005103251A3 Cancer specific promoters |
| 04/27/2006 | WO2005101004A3 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 04/27/2006 | WO2005100544A3 SMALL RNAs AND BACTERIAL STRAINS INVOLVED IN QUORUM SENSING |
| 04/27/2006 | WO2005100390A3 Bob-1 specific t cells and methods to use |
| 04/27/2006 | WO2005093080A3 Nitrile hydratase of rhodococcus |
| 04/27/2006 | WO2005092918A3 Targeting polypeptide |
| 04/27/2006 | WO2005090385A3 Compositions having antimicrobial activity and uses thereof |
| 04/27/2006 | WO2005085285A3 Nuclear hormone receptors |
| 04/27/2006 | WO2005049789A3 Synthetic mammalian retrotransposon gene |
| 04/27/2006 | WO2005040349A3 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 04/27/2006 | WO2005034853A3 Uses of interferons with altered spatial structure |
| 04/27/2006 | WO2005025603A3 Methods of using wisp antagonists |
| 04/27/2006 | WO2005021582A3 Methods for the early diagnosis of ovarian cancer |
| 04/27/2006 | WO2004094592A3 Polymer-conjugated glycosylated neublastin |
| 04/27/2006 | WO2004005486A3 Mp21s as modifiers of the p21 pathway and methods of use |
| 04/27/2006 | WO2003040333A3 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof |
| 04/27/2006 | WO2003033665A3 Secreted protein, ztnf9 |
| 04/27/2006 | US20060090223 Vectors to express desired amino acid sequence in cells; regeneration; endosperm tissues; rice, corn, wheat, barley |
| 04/27/2006 | US20060090220 Nucleotide sequences coding insecticidal for use in biological pest control; larvicides; growth inhibiting effect |
| 04/27/2006 | US20060090218 Method of controlling gene expression and gene silencing |
| 04/27/2006 | US20060090214 Method of treatment and an animal model useful for same |
| 04/27/2006 | US20060090213 Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions |
| 04/27/2006 | US20060090212 Novel human genes and proteins encoded thereby |
| 04/27/2006 | US20060089807 Identifying peptide modifications |
| 04/27/2006 | US20060089493 Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas |
| 04/27/2006 | US20060089492 DNA comprising promoter sequence, derived from a wild-type promoter of a methyltrophic yeast, whose transcription efficiency is modulated in comparison to the efficiency of the wild-type promoter by inserting or modifying a DNA binding site |
| 04/27/2006 | US20060089491 FAS Ligand Derived Polypeptides |
| 04/27/2006 | US20060089490 Survival motor neuron (SMN) gene: a Gene for spinal muscular atrophy |
| 04/27/2006 | US20060089326 Immunostimulatory nucleic acid molecules |
| 04/27/2006 | US20060089310 Treatment of infections and other disorders |
| 04/27/2006 | US20060089307 Peptides that bind to the heparin binding domian of vegf and vegfr-2 |
| 04/27/2006 | US20060089306 New epilepsy mutations |
| 04/27/2006 | US20060089303 Cancer-testis antigens |
| 04/27/2006 | US20060089302 Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases |
| 04/27/2006 | US20060089297 Sperm specific lysozyme-like proteins |
| 04/27/2006 | US20060088938 Methods and compositions for use in spliceosome mediated RNA trans-splicing in plants |
| 04/27/2006 | US20060088936 Raav expression systems for genetic modification of specific capsid proteins |
| 04/27/2006 | US20060088933 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 04/27/2006 | US20060088925 Fermentation for high cell density culture; thrombolytic agents; genetically engineered plasmid carries kanamycin resistant marker |
| 04/27/2006 | US20060088917 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/27/2006 | US20060088916 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |
| 04/27/2006 | US20060088914 Nucleotide sequences coding uncoupling protein for use in the diagnosis and treatment of nervous system disorders |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088912 Compositions and methods of purifying myelin-associated glycoprotein (MAG) |
| 04/27/2006 | US20060088909 Virus-like particles, methods of preparation, and immunogenic compositions |
| 04/27/2006 | US20060088908 Mutiens of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/27/2006 | US20060088907 Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor |
| 04/27/2006 | US20060088906 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 04/27/2006 | US20060088888 Methods of identifying inhibitors of GADD45 polypeptide activity, and inhibitors of such activity |
| 04/27/2006 | US20060088886 Topiramate analogs |
| 04/27/2006 | US20060088880 Methods and compositions for the treatment and diagnosis of cellular proliferation disorders using 25943 |
| 04/27/2006 | US20060088878 Purification of recombinant proteins fused to multiple epitopes |
| 04/27/2006 | US20060088877 Systematic evolution of ligands by exponential enrichment: Chemi-SELEX |
| 04/27/2006 | US20060088854 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/27/2006 | US20060088832 Tap-70, a novel marker for epithelial tumors |
| 04/27/2006 | US20060088830 Protein biomarkers that distinguish prostate cancer from non-malignant cells |
| 04/27/2006 | US20060088828 Polycystic kidney disease nucleic acids and proteins |
| 04/27/2006 | US20060088827 Diagnostic and therapeutic use of a voltage-gated ion channel scn2a for neurodegenerative diseases |
| 04/27/2006 | US20060088825 Human delta-n p73 molecules and uses thereof |
| 04/27/2006 | US20060088824 Used in assays to identify PAP-1/WIP-1 interaction inhibitors; West Nile virus (WNV) |
| 04/27/2006 | US20060088820 Detecting superantigen activity in a biological sample |
| 04/27/2006 | US20060088819 Truncated hepatitis C virus NS5 domain and fusion proteins comprising same |
| 04/27/2006 | US20060088554 Long lasting immunity to variety of Neisseria meningitidis strains |
| 04/27/2006 | US20060088551 Functional fragments of HIV-1 VPR protein and methods of using the same |
| 04/27/2006 | US20060088549 Chimeric virus vaccine |
| 04/27/2006 | US20060088548 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |